And the Wegovy pill isnt the last
This result often outperforms many traditional weight-loss interventions, especially in patients with obesity
Initially, main concerns were receptor-activating activity while recently, downstream effects of GLP-1R and GIPR have been more and more revealed that not only receptor activation promotes cAMP and stimulates insulin releasing, but also other factors (-arrestin recruitment, residence time, etc.) influence receptor internalization, which further elicits long-term effects in vivo
Furthermore, these studies have identified a threshold effect in male subjects, wherein fasting GLP-1 levels appeared to confer a protective effect against cancer risk [6]
The better question is: Can newer weight-loss treatments help people lose fat while protecting lean muscle, strength, and long-term metabolic health
J.HerzogH.CohenM